FDA-approved dialysis drug may help fight against antimicrobial resistance
Increased antibiotic use can lead, seemingly paradoxically, to more problematic infections, as the bacteria evolve to resist ...
News-Medical.Net2d
FDA-approved drug for chronic kidney disease may help mitigate antibiotic resistance
Increased antibiotic use can lead, seemingly paradoxically, to more problematic infections, as the bacteria evolve to resist ...
EurekAlert!3d
FDA-approved dialysis drug may help fight against antimicrobial resistance
Researchers found that orally administered sevelamer — a dialysis drug — can bind off-target antibiotics, shown being injected into the arm here, in the gut. Off-target antibiotics ...
EurekAlert!2d
Mitigating antibiotic resistance (IMAGE)
Researchers found that orally administered sevelamer — a dialysis drug — can bind off-target antibiotics, shown being injected into the arm here, in the gut. Off-target antibiotics, or antibiotics ...
pharmaphorum1d
Ardelyx’s ambition to revolutionise kidney treatment
Raab co-founded Californian company Ardelyx in 2007 after working for years at Genzyme, the developer of phosphate binder Renagel (sevelamer hydrochloride). Ardelyx aim is to develop and ...